Hot Movers: Gold Resource Corporation (NYSEMKT:GORO), Enzymotec Ltd (NASDAQ:ENZY), Biogen Idec (NASDAQ:BIIB), Kimberly Clark (NYSE:KMB)

Gold Resource Corporation (NYSEMKT:GORO) reports preliminary production results for the first quarter ended March 31, 2014 of approximately 23,700 precious metal gold equivalent ounces (AuEq). Gold Resource Corporation is a gold and silver producer with operations in the southern state of Oaxaca, Mexico. Gold Resource Corporation (NYSEMKT:GORO) shares after opening at $4.61 moved to $4.69 on last trade day and at the end of the day closed at $ 4.59. Company price to sales ratio in past twelve months was calculated as 1.98 and price to cash ratio as 16.58. Gold Resource Corporation (NYSEMKT:GORO) showed a negative weekly performance of -4.57%.

Enzymotec Ltd. (NASDAQ:ENZY) announced that on April 18, 2014 the US Patent and Trademark Office (“USPTO”) issued a final decision in the inter partes reexamination of Neptune Technologies & Bioressources, Inc. (NEPT) (“Neptune”) 8,030,348 patent rejecting all of the claims. Neptune may appeal this decision, but cannot submit any additional evidence or claim amendments. Enzymotec Ltd (NASDAQ:ENZY) shares advanced 0.67% in last trading session and ended the day on $19.64. Enzymotec Ltd (NASDAQ:ENZY) return on equity ratio is recorded as 11.80% and its return on assets is 9.30%.

Amunix Operating Inc. announced that Biogen Idec Inc (NASDAQ:BIIB) has exercised its option to enter into an exclusive, worldwide license agreement to research and develop novel, fully-recombinant Factor VIII products with improved therapeutic properties. Under the terms of the option agreement, Amunix will receive an upfront $1 million payment and will also be eligible to receive up to $38 million in clinical and commercial milestone payments. Biogen Idec Inc (NASDAQ:BIIB) shares moved up 2.56% in last trading session and was closed at $297.98 while trading in range of $290.20 – $298.57 – Biogen Idec Inc (NASDAQ:BIIB) year to date (YTD) performance is 6.59%.

Kimberly-Clark Corporation (NYSE:KMB) reported first quarter 2014 results and confirmed its previous guidance for full-year 2014 adjusted earnings per share. Kimberly Clark Corp (NYSE:KMB) weekly performance is 1.08%. On last trading day company shares ended up $110.94. Kimberly Clark Corp (NYSE:KMB) distance from 50-day simple moving average (SMA50) is 1.37%. Analysts mean target price for the company is $108.00.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *